gtag('config', 'UA-2081851-45');

The Battalion. (College Station, Tex.) 1893-current, March 18, 2002, Image 6

Below is the OCR text representation for this newspapers page. It is also available as plain text as well as XML.

r hwiR De'riGri 694-9755 118 Walton Hair Design 694-9755 April Graham Specializing in CORPS CUTS WEEKLY SPECIALS Monday, March 18, 2002 INTERNaJ the BAlJ Grenade attack in Pakista Protestant church kills fl\ ISLAMABAD, Pakistan (AP) — A grenade attack on a Protestant church packed with Sunday worshippers killed five people — including an American woman and her daughter — in an assault clearly aimed at Pakistan’s foreign community. No group claimed responsi bility for the attack, in which at least one young man in black — some witnesses said two — ran through the center of the church hurling grenades. But suspicion fell on Islamic extremists. Ten Americans were among the 45 people injured, most of whom were foreigners, police and hospitals said. One body remained unidentified late Sunday, and officials said it may be the assailant. President Bush condemned the attack on the Protestant International Church and called it an act of terrorism. He pledged to find those responsi ble and bring them to justice. Britain’s Foreign Secretary Jack Straw said the assault was aimed at undermining Pakistan’s pro-U.S. president at a time when he is trying to quell Islamic fundamentalism fol lowing the Taliban’s fall in neighboring Afghanistan. The attack occurred at 10:50 a.m. during a sermon before 60 to 70 worshippers. Dozens of police and soldiers rushed to the scene. The church, about 400 yards from the U.S. Embassy, is locat ed in the guarded diplomatic quarter in the heart of Pakistan’s capital and primarily serves the foreign community. The over whelming majority of Pakistanis are Muslim and few Pakistani Christians live in Islamabad. Survivors spoke of deafening blasts, choking smoke and pan demonium. They said terrified parents screamed for their chil dren and stunned worshippers dived beneath chairs and behind cement pillars as bits of flesh were hurled through the air. Parishioners sobbed and called out “Brother! Brother!” as they tried to find friends and family amid the chaos. u It was horrific. There was a horri ble smell and we could barely breathe Elisabeth Mundhenk victim Parents groped to find their way downstairs, where their children were attending Sunday School. Other parishioners feared touching the wounded, because unexploded grenades lay near their bodies. Witnesses gave conflicting reports on the number of attack ers. Late Sunday, senior police superintendent Nasir Khan Durrani said authorities believed only one attacker was involved. Durrani said the assailant may have died in the attack. "There was blood, blood, blood, intestines lying on the floor.” said Elisabeth Mundhenk, 54, of Hamburg. Germany as she awaited treatment for shrapnel wounds at a hospital. “It was hor rific. There was a horrible smell and we could barely breathe.” Mark Robinson of San Clemente, Calif., who was being treated at a clinic for a minor leg injury, described “total pandemonium.” “Everyone panicked,” Robinson said. “I saw one woman on the steps with a piece of shrapnel in her carotid artery. She bled to death right there.” The U.S. Embassy identified the dead Americans as Barbara Green and her daughter Kristen Wormsley, a senior at the American School in Islamabad. Green and her husband. Milton Green, worked at the U.S. Embassy — she in admin istration and he in the computer division. Milton Green and the couple’s young son were also injured but not seriously, according to police. The other dead included one Church atta Grenades were . Proteaent church inti Pakistan on Sunday^; people and injuriig^ ^77 jf ArGHAHtSTAN PAKISTri Footb « spring -4»>c»ViVY ^ Afghan, one Pakisur one unidentified, officials said. In addition Americans, 12 PaL: Iranians, one la Ethiopian and oik were injured, police government said tae also included Sn Afghans, Swiss. Australians andCani Six or seven wen: condition. District L Mehmood Khan Nani British aid won Parham, 36. told Bra Association news asr j attacker ran through th: the church, hurling ep | Four q for NC ksTBkM ty'hn 1 Religious police allegedly block resc London $294 Paris $335 Amsterdam $488 Madrid... $477 Rio de Janeiro...$772 San Jose C.R. ...$461 BUDGET HOTELS for as little as A NIGHT!!! fai Fares are round-trip. rf<| Restrictions may ^P^Y- Tax not includec STA TRAVEL 721 Texas Ave. S. 979.696.5077 www.sttattravel DUBAI, United Arab Emirates (AP) — Government-run newspapers in Saudi Arabia have accused the country’s reli gious police of preventing the rescue of girls trapped in a school fire because they were not wearing the long dresses and head coverings required in public. Fourteen girls died in the catastrophe last Monday at the 31st Girls Middle School in Mecca, some 470 miles southeast of Riyadh. Fifty others were injured, while hundreds of others escaped. The religious police, which have offices in every city, are routinely criticized privately in Saudi society, but this was believed to be the first time that newspapers in the kingdom have come out with harsh words against them. The newspapers accused members of the religious police — the Committee for the Propagation of Virtue and the Prevention of Vice — of blocking rescue attempts by male firefighters and paramedics because some of the girls were not wearing the mandatory Islamic dress, which covers the entire body and hair. “They forced the girls to remain inside the school and didn’t allow them to leave, saying that their hair wasn’t covered and they weren't wearing the abaya (long robe),” the Al-Eqtisadiah newspaper said, citing firefighters and police. The government-run Saudi Gazette said 835 students and 55 teachers were in the building at the time of the fire, which broke out a half-hour after classes started. The Saudi Press Agency said I The Tex^ team will spring drill Bt 4 p.m. I The Agg i season wit and wrapp with a 28-S3 the Galie Bowl in Ho 1 A&M retu Including Bhe lone lo graduatin g Beth McKin 50 games f Renter. Seni feethel Johr ■or the sprir a ruptured second garr Rnd missed ■if the seasc 1 A&M will t & White C April 6 at 1 : students started screaming, setting off a stampede fori Initial reports said some gates were locked becaus who had the key was away. But Al-Eqtisadiah quoted fied civil police officers as saying that religiouspolia the gate and refused to move even after rescuers/rift' vince them that the situation was very serious. According to the newspaper reports, most oi fe @ either suffocated, fell from the windows of the fas-W 5 ' 1 ing or were trampled to death. ^ The head of Mecca's police. Brig. Mohan ] told The Associated Press on Sunday that he arrivedauP to find a member of the religious police “trying toin'T “He was fighting with a police officer, trying topflf from entering the school,” al-Harthy said. “1 iMf instructed him to leave and he did.” L 1 he director of the religious police, Sheik Jabet^w denied his people prevented rescuers from entering T I here are some who are trying to pin the death ofi : on the committee,” he said. The fire has led to a domestic debate and an intemat f cry. with Amnesty International demanding a public It these reports are true, this is a tragic illustraibl gender discrimination can have lethal consequences, i ization said in a written statement. i Three-time lion senior turned in e finish on tf springboard place finish c to capture th ing spot in t Swimming ChampionsFi p In addition more Katie W ior Callie Petr a spot in Championshi See B* Contraceptive Injection corvtrol youirhink as.out jus-t M-xayear medroxyprogesterone acetate injectable suspension DEPO-PROVERA* Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP) This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive Injection? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intramuscular injection (a shot) in the buttock or upper arm once every 3 months (I 3 weeks). To continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months (13 weeks) DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries dunng the second half of your menstrual cycle. DEPO-PROVERa acts by preventing your egg cells from ripening. If an egg is not released from the ovaries during your menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA also causes changes in the lining of your uterus that make it less likely for pregnancy to occur How effective is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROVERA Contraceptive Injection?”) To make sure you are not pregnant when you first get DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during the first 5 days of a normal menstrual period, ONLY within the first 5 days after childbirth if not breast-feeding; and, if exclusively breast-feeding, ONLY at the sixth week-after childbirth. It is a long-term injectable contraceptive when administered at 3-month (13-week) intervals. DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable methods of birth control available. This means that the average annuaf pregnancy rate is less than one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptVe methods depends in part on how reliably each woman uses the method. The effectiveness of DEPO-PROVEPA depends only on the patient returning every 3 months (I 3 weeks) for her next injection. Your health-care provider will help you compare DEPO-PROVERA with other contraceptive methods and give you the informatiorr you need in order to decide which • if you have had cancer of the breast • if you have had a stroke • if you have or have had blood dots (phlebitis) in your legs • if you have problems with your liver or liver disease • if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other ingredients). What other things should I consider before using DEPO-PROVERA Contraceptive Injection? You will have a physical examination before your doctor prescribes DEPO-PROVERA It is important to tell your health-care provider if you have any of the following: • a family history of breast cancer • an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples • kidney disease • irregular or scanty menstrual periods • high blood pressure • migraine headaches *. asthma • epilepsy (convulsions or seizures) • diabetes or a family history of diabetes • a history of depression • if you are taking any prescription or over-the-counter medications This product is intended to prevent pregnancy. It does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. <6 Other Riste hormone-based contraceptives may have an increased risk of blood clots or Ateo if a contraceptive method fails, there Is a possibility that the fertilized egg will begm inn outside of the uterus (ectopic pregnancy) While these events are rare, you should to develop orovider if you have any of the problems listed in the next section What symptoms maj signai probiems white using DEPO-PROVERA oTy ofrhSbh<ah8^rov " e r immediately if any of these problems occur following an injection ? f sharp < chestpafn R up of blood, or sudden shortness of breath (indicating a possible dot . sudden" severe headache or vomiting, dizzinessorfaintiiw. problems with your eyesight or s^eelh weakness, or numbness in an arm or leg ('"die at ing a possible stroke) • severe pain or swelling In the calf (mdicating a possible dc? In the leg) • unusually heavy vaginal bleeding abdominal area • severe pain or tenderness n 1 ^Ttte • persistent pain, pus, or bleeding at the injejcuonjite What are the | re the possible side effects of DEPO-PROVERA Contraceptive Injection? vrvfrnav exocrience a weight gam while you are using DEPO-PROVERA About two thirds of 2°' J 5/hn used DEPO-PROVERA in clinical trials reported a weight gam of about 5 pounds vea?ofYou may continue to gam weight after the finl year Women in one f un ^ l DEPO PROVERA for 2 years gained an average total of 81 pounds ever [Tf 3 ^r, or aocirovniately 4 pounds per year Women who continued for 4 years gained an average toteTof I ^ pounds ^/er those 4 years, or ^ What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off Eased on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that e years, or appnoximatetv i s77* ' years gamed an who continued for & years gained an average total of IA s e r2r,..kj Pounds per Y ear Women approximately 2 75 pounds per year pounds over those 6 years or In a clinical study of over 3,900 women who used DEPO-PROvco a < women reported the following effects that may or mav not or U P 1 DEPO-PROVERA: Irregular menstrual bleeding, amenofrhe? ^.^? n . ne J a,e ' contraceptive method is the i : choice , for you. The following table shows the percent of women who got pregnant while using different kinds of contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected in women who use each method exactly as it should be used) and the typical rate of pregnancy (which includes women who became pregnant because they lorgot to use their birth control or because they did not follow the directions exactly). Percent of Women Experiencing an Accidental Pregnancy in the First Year of Continuous Use bleeding amenon+iM "^ted^o thekuseof about half of those who become pregnant will do so in about 10 months after their last injection, cramps, dizziness, weakness or fatigue, decreased sexual HocinJi e ‘ nervDusness . abdominal about two thirds of those who become pregnant will do so in about 12 months; about 83% of discharge or irritation, breast swelling and tenderness bloatinn^' those who become pregnant will do so in about 15 months; and about 93% of those who become backache, depression, insomnia, acne, pelvic pain, no hair I irregular Menstrual Bleeding months; and about 93% of those who become of time you use , it aft§r you stop using it Contraceptive Injection? discharge or irritation, breast swelling and tenderness bloatmo^/ t cra 7 > P s - n <»usea, vaginal backache, depression, insomnia, acne, pelvic pain, no hair growth or^f ,n ^ ° f * he hands or feet, flashes, and joint pain. Other problems were reported by very few Slve ha,r rash * hot trials, but some of these could be serious. These include rrvrC,T;i °’ trvs ““ infections, alleryi.- f,intino c ?"vul S ,ons, ■h(H= ei I.? w , of the . women in the clinical jaundice, urinary tract ~ ‘ vein Student Services at A.P. Bee* Health will not be of Wednesdaj March 20, rvic reactions, fainting, paralysis, osteoporosis lade of rl*t J aunc,,ce ' urinary thrombosis, pulmonary embolus, breast cancer or cervical cAnrar ir* r Lf tum to <teep The side effect reported most frequently by women who use DEPO-PROVERA for occur during your use of DEPO-PROVERA. discuss them ll he ¥ L or an / ot her problems contraception is a change in their normal menstrual cycle During the first year of using Should any precautions be followed durinn '^•jH-caneprovider DEPO-PROVERA. you might have one or more of the following changes irregular or Contraceptive Injection? y ® of DEPO-PROVERA Method Lowest Expected Typical DEPO-PROVERA 0.3 0.3 Implants (Norplant) 0.2- 02* Female sterilization 0.2 0.4 Male sterilization 0.1 0.15 Oral contraceptive (pill) 3 Combined : 0.1 Progestogen only 0.5 IUD 3 Progestasert 2.0 Copper T 330A 0.8 Condom (without spermidde) 2 12 Diaphragn (with spermidde) 6 18 Cervical cap 6 18 Withdrawal 4 18 Periodic abstinence 1-9 20 Spermidde alone 3 21 Vaginal Sponge used before childbirth 6 18 used after childbirth 9 28 No method £5 , 85 unpredictable bleeding or spotting, an increase or decrease in menstrual bJeeddig, or no bleeding at all. Unusually heavy or continuous bleeding, however; is not a usual effect of DEPO-PROVERA; and if this should see your heafth-care provider right away. With continued use of perioas may DEPO-PROVERA, bleed|ng^usuan/^decnsases. and many women stop having periods completely regularly ever .1 many women stop r ^., In clinical studies of DEP'O-PROVERA, 55% of the women studied reported no menstrual bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual bleeding after 2 years of use The reason that your periods stop is because DEPO-PROVERA causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the . regular monthly growth of the lining of your uterus does not occur and. therefore, the bleeding that comes with your normal menstruation does not take place. When you stop using DEPO-PROVERA your menstrual period will usually, in time, return to its normal cycle. 2 Bone Mineral Changes Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in your bones. This could increase your risk of developing bone fractures. The rate of bone mineral loss is greatest in the early years of DEPO-PROVERA use, but after that, it begins to resemble the normaT rate of age-nelated bone mineral loss. SCancer Studies of women who have used different forms of contraception found that women who used DEPO-PROVERA for contraception had no increased overall risk of developing cancer of the breast, ovary, uterus, cervix, or liver. However, women under 35 years of age whose first exposure to DEPO-PROVERA was within the previous 4 to 5 years may have a slightly increased risk of developing breast cancer similar to that seen with oral contraceptives. You should discuss this with your healtn-care provider 4 .Unexpected Pregnancy regularly every that you may be pregnant, see your heaith-care provider Test Interaction- problib'ly^o^premarrt^'rr 0 ^^ 0 ^'^^®^ , , „ . .. r .vider pregnarrt ' Howe '^'-. if you think 2.Laboratory Test Interactions If you are scheduled for any laboratory tests, tell your health DEPO-PROVERA for contraception Certain blood ten- are that you DEPO-PROVERA ests ane aff ected by hormones 'rug I :adre DEPO-PROVERA. S.Drug Interactions Q - z — — •-> using oy hormones such as .^himide') is an anticancer drug that may significantly decrease the ^ re pe^s'ofEPO-PROVtRA if the two drugs are given during the same time. e Nursing/Voters A passed to the nursing infant in the breast milk, no harmful Although DEP P f I-Tf lTth ese children DEPO-PROVERA does not prevent the breasts from effects nave been i™™ d ^ nursing mothers. However to minimize the amount of produdng milk ot it can be use |n the first after b|rth 5EPO-PROVERA that is passed to xne DEPO-PROVERA '' 6 weeks after childbirth before you, po _ pBOVERA Conlr , Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental Source: Trussed et al. Obstet Gyneco/. l99Q76;558-567. ’•From Norplant® package insert. Who should not use DEPO-PROVERA Contraceptive Injection? Not all women should use DEPO-PROVERA You should not use DEPO-PROVERA if you have any of the following conditions • if you think you might be pregnant • if you have any vaginal bleeding without a known reason -miwuiu wait until for contraceprtion How often do I get my shot of DEPO-PROVERA Contraceptive Injection? The recommended dose of DEPO-PROVERA is 150 mg every 3 months (13 weeks) given in a single intramuscular injection in the buttock or upper arm To make sure that you are not pregnant at f)ie time of the first in|ection, it is essential that the iniection be given ONLY during the first 5 days of a normal menstrual period. If used toiiowng the delivery of a child, the first infection of DEPO-PROVERA MUST be given within 5 days after childbirth if you are not breast-feeding or 6 weeks after childbirth if you are exclusively breast-feeding. If you wait / 3 vJeeks! between miertinnc or lonoor than h " ,. _ regularly (every 3 months [13 weeks]) is very low. (I 3 weeks) between injections, or longer than 6 weeks after riel(2!l. wa ' t °r i 8 er than 3 months While there have been reports of an increased risk of low birth weight and neonatal infant death should determine that you are not pregnant before givinp vm i your health-care provider or other health problems in infants conceived dose to the time of injection, such pregnancies are 6 s ' u “ our Election of DEPO-PROVERA uncommon. If you think you may have become pregnant while nsino DFPO-PROVFRA for Rx only , contraception, see your health-care provider as soon as possible. SAIIergic Reactions Some women using DEPO-PROVERA Contraceptive Injection have reported severe and CB-7-S potentially life-threatening allergic reactions known as anaphylaxis and anaphylactoid reactions. . Symptoms include the sudden onset of hives or swelling and itching of the skin, breathing Pharmacia & Upj< difficulties, and a drop in blood pressure. . Kalamazoo, Ml 4' john Company 9001, USA Pharmacia & Upjohn The sta participate an in-sen^ workshop" 1 Student Counst Services. Stof on Dial-A-Nutf will resume 3:30 PM, March do EMS/Ambula' 1 Service will be avails (9-911)